Almost across the board in biotech, IND's that would cause a doubling of share price a couple years ago are barely making a ripple today. Days of true bargain basement prices are coming but the need to be selective will be paramount. Those companies that truly have something will yield an even greater multiple...
News 
Market Data 
Discover 
